What the research found

Researchers at Karolinska Institutet discovered that your gut bacteria can synthesise a class of molecules called dinitrosyl iron complexes (DNICs) by combining dietary nitrate and non-haem iron. This happens when you consume vegetables high in both compounds—beetroot, spinach, and leafy greens are rich sources—and your microbiota breaks them down into these bioactive molecules, which then get absorbed and distributed to organs like the liver and kidneys.

The team demonstrated this mechanism using mice, cultured cells, bacteria, and human tissue samples. A critical clue came from germ-free mice (raised without any microbiota), which produced no DNICs at all—proving the bacteria are essential for this conversion. When DNIC levels were artificially increased in an animal disease model, several markers improved: blood pressure dropped, blood vessel function enhanced, glucose control tightened, and hepatic fat accumulation decreased.

Why it matters for you

If you're optimising metabolic and cardiovascular health via tracking, this offers a mechanistic explanation for why vegetable-heavy diets consistently show up as protective in epidemiology. You're not just getting micronutrients; your gut bacteria are actively manufacturing signalling molecules that improve insulin sensitivity, vascular tone, and liver function—biomarkers many of you monitor.

The practical angle: this mechanism depends on both nitrate and iron reaching your colon intact. If you supplement nitrate (beetroot juice, sodium nitrate) or iron without a healthy microbiota to do the conversion, you might miss this benefit. Conversely, if your microbiome is compromised—say, by repeated antibiotics or poor diet—you could be losing this layer of metabolic regulation even if you're eating the right foods. This is why microbiota-supportive practices (fibre intake, fermented foods) might matter more than isolated supplement protocols.

Caveats

• Preclinical stage: findings are primarily from mouse models and cell cultures; no human dosing or outcome studies yet
• Measurement gap: there's currently no reliable way to measure DNICs in living people, so you can't yet track this biomarker yourself
• Mechanism incomplete: how DNICs move through the body and which specific physiological pathways they activate remains unclear
• Individual microbiota variation: the efficiency of DNIC synthesis likely varies dramatically between people depending on bacterial composition—a one-size-fits-all recommendation isn't justified yet